UBS Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Sell
58,120
-77,695
-57% -$1.26M ﹤0.01% 6142
2025
Q4
$2.34M Buy
135,815
+97,086
+251% +$1.88M ﹤0.01% 4826
2025
Q3
$997K Sell
38,729
-15,039
-28% -$568K ﹤0.01% 5575
2025
Q2
$3.09M Sell
53,768
-6,502
-11% -$521K ﹤0.01% 4361
2025
Q1
$6.52M Buy
60,270
+7,626
+14% +$664K ﹤0.01% 3509
2024
Q4
$2.5M Buy
52,644
+27,018
+105% +$1.63M ﹤0.01% 4511
2024
Q3
$2.52M Sell
25,626
-552
-2% -$71.3K ﹤0.01% 3767
2024
Q2
$4.28M Sell
26,178
-9,559
-27% -$1.36M ﹤0.01% 3017
2024
Q1
$5.45M Buy
35,737
+33,574
+1,552% +$5.59M ﹤0.01% 2883
2023
Q4
$679K Sell
2,163
-2,240
-51% -$811K ﹤0.01% 4836
2023
Q3
$1.96M Sell
4,403
-6,060
-58% -$2.74M ﹤0.01% 3456
2023
Q2
$4.54M Buy
10,463
+7,983
+322% +$4.49M ﹤0.01% 2690
2023
Q1
$1.47M Buy
2,480
+1,104
+80% +$618K ﹤0.01% 3746
2022
Q4
$555K Sell
1,376
-68
-5% -$31.9K ﹤0.01% 4617
2022
Q3
$846K Sell
1,444
-518
-26% -$310K ﹤0.01% 3890
2022
Q2
$1.07M Sell
1,962
-532
-21% -$269K ﹤0.01% 3682
2022
Q1
$1.58M Buy
2,494
+625
+33% +$322K ﹤0.01% 3668
2021
Q4
$1.26M Buy
1,869
+512
+38% +$312K ﹤0.01% 4179
2021
Q3
$889K Buy
1,357
+1,350
+19,286% +$1.15M ﹤0.01% 4288
2021
Q2
$7K Buy
+7
New +$6.13K ﹤0.01% 8306

Other funds holding AGL